Journal of Medicinal Chemistry · 2000 · 31 citations · 4 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryLead OptimizationStructure-activity RelationshipsHit-to-lead OptimizationLead Compound DesignPotency OptimizationQuantitative Structure-activity RelationshipsSelectivity OptimizationStructure-activity Relationship AnalysisChemical Structure-activity RelationshipsChemical Synthesis Of AnaloguesEnzyme ActivityEnzyme Activity AssaysInhibitor ClassificationMedicinal Chemistry ApplicationsPde5 InhibitorsStructure - Pharmacokinetic Relationship Analysis
A previous report from these laboratories identified the N-3-benzylimidazoquinazolinone nucleus as a more selective PDE5 inhibitor template compared to the pyrazolopyrimidine of sildenafil. This paper describes in detail the structure-activity relationships of a set of sulfonamide analogues, several of which are both more potent and more selective PDE5 inhibitors in vitro than sildenafil. The synthesis, in vitro enzyme activity and selectivity, and in vitro functional and preclinical pharmacokinetic assessment of molecules in this series are described.
4